• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Drug-Associated Disease: Cytochrome P450 Interactions
Drug-Associated Disease: Cytochrome P450 Interactions

... Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, 7-153 WDH, 308 Harvard Street SE, Minneapolis, MN 55455, USA ...
L-35 Drugs and Medicines
L-35 Drugs and Medicines

... earliest attempts at this, involved use of various plants. The knowledge was based on experience and was handed on from generation to generation. It is being used even today. In an attempt to conquer pain and disease, a large number of synthetic chemicals have been discovered. The chemicals used as ...
doc Notes on Lecture 2
doc Notes on Lecture 2

... 3) new formulation (old drug in a skin patch) 4) new combination (2 drugs not marketed together before) 5) already marketed drug product (patents expired) 6) New use for a drug product (minoxidil) minoxidil was originally researched to treat high blood pressure but now it is used to re-grow hair a d ...
Choosing a Statin to Lower Cholesterol
Choosing a Statin to Lower Cholesterol

... There is HDL (good) cholesterol and LDL (bad) cholesterol. If you have too much LDL cholesterol, it can build up on the walls of blood vessels. This build-up can clog the blood vessels and lead to a heart attack or stroke. ...
Slide 1
Slide 1

... – Careful examination of type and amount of surfactant in the formulation ...
Untitled - AntonioDeVuono
Untitled - AntonioDeVuono

... spontaneous reporting of adverse drug reactions (ADRs), in order to have a wide variety of information. The Italian Drug Agency (Agenzia Italiana del Farmaco [AIFA]) is financing several projects to increase reporting. In Calabria, a PV information center has been created in 2010. Materials and Meth ...
g 0 pH 7.2
g 0 pH 7.2

... Long acting formulations have advantages for medi material unexpectedly can give excellent medicament cal treatment, since the dosing frequency is decreased dissolution results. and this increases compliance with the prescribed dos All parts and percentages herein are by weight unless ...
C4: A-Z Drug Glossary and Acronyms
C4: A-Z Drug Glossary and Acronyms

... produces euphoria, increased confidence and feelings of control, energy, reduces the need for sleep and suppresses appetite. Cocaine blocks the reuptake of dopamine, noradrenaline and serotonin at presynaptic locations, thereby increasing these neurotransmitters at postsynaptic receptor sites. Toler ...
New Psychoactive Substances
New Psychoactive Substances

... Although precautionary approaches taken by some governments in creating pre-emptive legislation may remove some NPS from a widely accessible market, the reality is that as soon as one substance is made illegal, several others have appeared within days/weeks to take its place. The rapidly evolving na ...
mutism in autism
mutism in autism

... Has the discovery platform been validated ? What is ASD-002’s “Mechanism of Action (MoA)? Was the target walidated (MoA) in animal studies? What is ASD-002’s “Proof-of-concept” (PoC) ? Isn’t it difficult to diagnose ASD before 24 months? Is ‘language regression’ age-specific ‘mutism’ ? Why not just ...
STV(])FES O!}{(])CJ(vq POqt£/ffl1flLS
STV(])FES O!}{(])CJ(vq POqt£/ffl1flLS

... a proficient cow that supplies him with butter". In balancing the low chances of practical clinical success in medicinal research against necessity to build up our store house of knowledge, medicinal scientists have to rely on inner strength and purposeful determination. The small club of medicinal ...
Regulatory Considerations in the Post-Vioxx Era
Regulatory Considerations in the Post-Vioxx Era

... performed. Because of the limited data regarding long-term use of Celebrex, the lowest possible dosing was recommended (200 mg per day) and alternative therapies for high-risk GI patients were suggested.1 Only a few months later, in April 1999, Merck’s Vioxx (rofecoxib) tablets got a unanimous recom ...
Effect of Fruit/Vegetable-Drug Interactions on CYP450, OATP and p
Effect of Fruit/Vegetable-Drug Interactions on CYP450, OATP and p

... common drugs interacting with fruits and vegetables. The inhibition of their metabolism by fruits and vegetables can cause serious toxic effects, e.g., hypertension, poor glycemic control, rhabdomyolosis and drug overdose-related toxic effects. Overall, active components of fruits and vegetables can ...
Public Safety Substance Abuse Journal by MEDTOX June 2009
Public Safety Substance Abuse Journal by MEDTOX June 2009

... professionals working in the field of drug treatment in correctional settings; we've found one of those books. In "Substance Abuse Treatment with Correctional Clients: Practical Implications for Institutional and Community Settings", a book writtenby Barbara Sims, readers are provided a non-technocr ...
stay alcohol DRUG FREE and - Southeast Missouri Behavioral Health
stay alcohol DRUG FREE and - Southeast Missouri Behavioral Health

... CNS depressants should not be combined with any medication or substance that causes drowsiness, including prescription pain medicines, certain OTC cold and allergy medications, or alcohol. If combined, they can slow breathing, or slow both the heart and respiration, which can be fatal. Discontinuing ...
Users Guide - AHFS Drug Information
Users Guide - AHFS Drug Information

... an IRS 501(c)(6) tax-exempt entity. Drugs designated as orphan drugs by FDA and those otherwise considered as orphans are described. An orphan drug is one that is used for the treatment of a rare disease or condition that either occurs in fewer than 200,000 individuals in the US or is more prevalent ...
NOVEL DRUG DELIVERY SYSTEMS FOR ANTIFUNGAL THERAPY    Review Article  SADHNA KHATRY *, SIRISH
NOVEL DRUG DELIVERY SYSTEMS FOR ANTIFUNGAL THERAPY    Review Article  SADHNA KHATRY *, SIRISH

... subcutaneous, connective, and bone tissue.   Systemic or deep mycosis are able to infect internal organs and  become  widely  disseminated  throughout  the  body.  This  type  is  often fatal.  ...
choosing the right medical treatment and recent advances
choosing the right medical treatment and recent advances

... – Not known whether excreted in human milk. – Metabolized in liver. Dosage adjustment is required in patients with moderate and greater renal or hepatic impairment . ...
Toward a Drug-Free University
Toward a Drug-Free University

... drugs on school property or as part of any school activity. This policy clearly states that sanctions apply to student acts committed under the influence, such as public disturbances, endangerment to self or other, or property damage. It is the intent of this document: 1. To communicate the concern ...
1 Hazardous Drug handling policy
1 Hazardous Drug handling policy

... • Hazardous Drug – LOW – includes other than antineoplastic and carcinogenic agents For a complete listing of hazardous drugs, see Hazardous Drugs List. There are 2 levels of precautions when handling hazardous drugs: • Cytotoxic precautions are used when handling hazardous drugs – high and medium c ...
Assessment of Drug−Lipid Complex Formation by a High
Assessment of Drug−Lipid Complex Formation by a High

... Phospholipidosis, the accumulation of phospholipids in cells, is a relatively frequent side effect of cationic amphiphilic drugs. In response to the industry need, several methods have been recently published for the prediction of the phospholipidosis-inducing potential of drug candidates. We descri ...
Biomarkers: An indispensible addition to the
Biomarkers: An indispensible addition to the

... of ‘safer drugs, in greater numbers, approved more quickly’1. In recent times, the conventional approach has been courting failure more than it has success. The attrition rate for drugs in clinical development is high: the percentage of tested products entering phase I trials that eventually gain re ...
8/30/10 How to use Introduction
8/30/10 How to use Introduction

... Antiepileptic drugs grouped according to their major mechanism of action. Some AEDs work by acting on a combination of channels and/or some unknown mechanism of action. Target of seizure control Rx epilepsy is achieving balance between factors influence excitatory postsynaptic potential (EPSP) and t ...
IDE_IND_KMFINAL_plusAEslide_090310
IDE_IND_KMFINAL_plusAEslide_090310

... Botanical products are finished, labeled products that contain vegetable matter as ingredients. Are Investigational New Drug (IND) applications required for clinical studies of botanical products that are also lawfully marketed as dietary supplements in the U.S.? ...
Captisol‐enabled™ Busulfan Non‐Confidential Summary October 2014
Captisol‐enabled™ Busulfan Non‐Confidential Summary October 2014

... Each vial of BUSULFEX contains 60 mg (6 mg/mL) of busulfan, the active ingredient, a white crystalline  powder with a molecular formula of CH3SO2O(CH2)4OSO2CH3 and a molecular weight of 246 g/mole.  Busulfan is dissolved in N,N‐dimethylacetamide (DMA) 33% vol/vol and Polyethylene Glycol 400, 67% vol ...
< 1 ... 37 38 39 40 41 42 43 44 45 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report